1,554
Views
15
CrossRef citations to date
0
Altmetric
Perspective

Atrial fibrillation and heart failure- results of the CASTLE-AF trial

, , , , , & show all
Pages 208-210 | Received 31 Mar 2018, Accepted 26 Jun 2018, Published online: 23 Aug 2018

References

  • Michniewicz E, Mlodawska E, Lopatowska P, et al. Patients with atrial fibrillation and coronary artery disease - double trouble. Adv Med Sci. 2017;63:30–35.
  • Lip GY, Brechin CM, Lane DA. The global burden of atrial fibrillation and stroke: a systematic review of the epidemiology of atrial fibrillation in regions outside North America and Europe. Chest. 2012;142:1489–1498.
  • Wong CX, Brown A, Tse HF, et al. Epidemiology of Atrial Fibrillation: the Australian and Asia-Pacific Perspective. Heart Lung Circ. 2017 Sep;26:870–879. Epub 2017 May 24.
  • Shah SR, Alweis R. Acute coronary artery dissection: a review of the literature and current evidence. Cardiology in Review. 2017 Dec 12; 1. DOI:10.1097/CRD.0000000000000186.
  • Naccarelli GV, Varker H, Lin J, et al. Increasing prevalence of atrial fibrillation and flutter in the USA. Am J Cardiol. 2009;104:1534–1539.
  • Rosamond W, Flegal K, Friday G, et al. Heart disease and stroke statistics–2007 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation. 2007;115:e69–171.
  • National Heart Lung, and Blood Institute. National Institutes of Health. In: Congestive Heart Failure in the USA: A New Epidemic. 1996. Available from: http://www.nhlbi.nih.gov/health/public/heart/index.htm
  • Shah SR, Fatima M, Dharani AM, et al. Bioresorbable vascular scaffold versus metallic stent in percutaneous coronary intervention: results of the AIDA trial. J Community Hosp Intern Med Perspect. 2017 Oct 18;7(5):307–308. eCollection 2017.
  • Jones DG, Haldar SK, Hussain W, et al. A randomized trial to assess catheter ablation versus rate control in the management of persistent atrial fibrillation in heart failure. J Am Coll Cardiol. 2013;61:1894–1903.
  • Di Biase L, Mohanty P, Mohanty S, et al. Ablation versus amiodarone for treatment of persistent atrial fibrillation in patients with congestive heart failure and an implanted device: results from the AATAC multicenter randomized trial. Circulation. 2016;133:1637–1644.
  • Shah SR, Uddin MF, Lateef N, et al. Evolocumab to reduce cardiovascular events: results of the (FOURIER) multinational trial. J Community Hosp Intern Med Perspect. 2017 Jul 13;7(3):199–200. eCollection 2017 Jul.
  • Hunter RJ, Berriman TJ, Diab I, et al. A randomized controlled trial of catheter ablation versus medical treatment of atrial fibrillation in heart failure (the CAMTAF trial). Circ Arrhythm Electrophysiol. 2014;7:31–38.
  • Prabhu S, Taylor AJ, Costello BT, et al. Catheter ablation versus medical rate control in atrial fibrillation and systolic dysfunction: the CAMERA-MRI study. J Am Coll Cardiol. 2017;70:1949–1961.
  • Shah SR, Fatima K, Ansari M. Recovery of myofilament function through reactivation of glycogen synthase kinase 3β (GSK-3β): mechanism for cardiac resynchronization therapy. J Interv Card Electrophysiol. 2014 Dec;41(3):193–194.
  • Marrouche NF, Brachmann J, Andresen D, et al. Catheter ablation for atrial fibrillation with heart failure. N Engl J Med. 2018;378:417–427.
  • Shah SR, Alweis R, Shah SA, et al. Effects of colchicine on pericardial diseases: a review of the literature and current evidence. J Community Hosp Intern Med Perspect. 2016 Jul 6;6(3):31957. eCollection 2016. Review.
  • Waks JW, Josephson ME. Mechanisms of atrial fibrillation – reentry, Rotors and Reality. Arrhythmia & Electrophysiology Review. 2014;3(2):90–100.